MBIOMICS
MBIOMICS
Social Links:
Industry:
Biotechnology
Founded:
2020-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.mbiomics.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Biomics
Biomics is a biotechnology company.
Evictas
Evictas is a biotechnology company.
Microgenetics
Microgenetics is a biotechnology company.
Mymetics Corp.
Mymetics Corp is a Swiss based biotechnology company,
VemiCo
VemiCo is a biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.mbiomics.com
- Host name: w0e.rzone.de
- IP address: 81.169.145.78
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "mbiomics"
mbiomics – mbiomics
We design and develop complex microbiome-based therapeutics to change the treatment paradigm of severe and chronic diseases. Bringing together proprietary precision analytics and …See details»
mbiomics - Crunchbase Company Profile & Funding
Mbiomics is a biotechnology company. View contacts for mbiomics to access new leads and connect with decision-makers. Develops treatments targeting …See details»
mbiomics GmbH - LinkedIn
We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a...See details»
Mbiomics Company Profile 2024: Valuation, Funding & Investors
Mar 23, 2023 · Information on valuation, funding, cap tables, investors, and executives for Mbiomics. Use the PitchBook Platform to explore the full profile.See details»
mbiomics Company Profile - Office Locations, Competitors, …
Mbiomics is a biotech company that provides clinical applications for microbiome-based therapeutics. It offers mbiomics MONITOR which allows to track microbiome modulation with …See details»
mbiomics - VentureRadar
Website: https://mbiomics.com Offers targeted microbiome profiling through patented precision technology, enabling quantitative resolution and faster analysis for clinical applications and …See details»
MIG Capital
Mar 23, 2023 · MIG Capital AG, one of Germany’s leading venture capital firms, announced today that it is investing in mbiomics GmbH, a pioneering microbiome biotech company developing …See details»
mbiomics - Products, Competitors, Financials, Employees, …
Mar 24, 2023 · Investors of mbiomics include High-Tech Grunderfonds, Bayern Kapital and MIG Capital. mbiomics specializes in the design and development of microbiome-based …See details»
mbiomics - Contacts, Employees, Board Members, Advisors
Mbiomics has 3 current employee profiles, including CMO and Co-Founder Markus Rinecker. mbiomics is a biotechnology company.See details»
Microbiome therapeutics biotech mbiomics raises EUR 13 million …
Munich, Germany, 23 March 2023 – mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced today …See details»
mbiomics GmbH cashes in €13m in Series A financing
Mar 25, 2023 · Munich-based microbiome therapeutics specialist mbiomics GmbH has raised €13m in the first closing of Series A round led by MIG Capital.See details»
Mbiomics
Mbiomics LLC is a bioinformatics research and consulting company that aims to apply computational biology and bioinformatics solutions to biological and biomedical scientific …See details»
mbiomics - News, Articles etc. - European Pharmaceutical Review
May 8, 2024 · News stories and articles referencing mbiomics on European Pharmaceutical Review Recommended New webinar with Fujifilm: Monocyte activation test (MAT): Insight into …See details»
Mbiomics
Mbiomics offers a wide diversity of bioinformatics and data analytics services including Statistical analysis of epidemiological surveys and disease projections. Clinical data management, …See details»
Microbiome therapeutics developer mbiomics receives €13 million …
Mar 23, 2023 · The pioneering microbiome biotech company based in Munich, Germany, is developing the first generation of effective microbiome-based therapeutics. mbiomics uses its …See details»
Mbiomics GmbH. (3/23/23). "Press Release: Microbiome …
Mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced today the first closing of EUR 13 million …See details»
mbiomics Appoints Seasoned Microbiome Expert Christopher …
About mbiomics mbiomics designs and develops complex microbiome-based therapeutics to change the treatment paradigm of severe and chronic diseases. Bringing together proprietary …See details»
mbiomics raises €13M to develop microbiome therapies
Mar 24, 2023 · mbiomics GmbH, a German microbiome biotech company developing the first generation of effective microbiome-based therapeutics has closed €13 million ($ 15 million) of …See details»
Mbiomics raises €13M to pivot to microbiome-based therapeutic ...
Mar 23, 2023 · Mbiomics GmbH raised €13 million (US$14.2 million) in a first close of a series A round that will enable it to pivot from being a microbiome analytics firm to becoming a …See details»
Microbiome therapeutics biotech mbiomics raises EUR 13 million …
Munich, Germany, 23 March 2023 – mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced today …See details»